Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 18, Issue 20
October 20, 2000
 

Down EDITORIALS
Down BREAST CANCER
Down HEMATOLOGIC MALIGNANCIES
Down BRAIN TUMORS
Down GASTROINTESTINAL CANCER
Down PHASE I AND CLINICAL PHARMACOLOGY
Down ASCO SPECIAL ARTICLE
Down ASCO SPECIAL ARTICLES
Down SPECIAL DEPARTMENTS
  Down ERRATA

Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
EDITORIALS Back
Gynecologic Surveillance of Women on Tamoxifen: First Do No Harm
Carolyn D. Runowicz
JCO Oct 20 2000: 3457–3458. [Full Text] [PDF]  
 
BREAST CANCER Back
Effect of Adjuvant Tamoxifen on the Endometrium in Women With Breast Cancer: A Prospective Study Using Office Endometrial Biopsy
  R. R. Barakat, T. A. Gilewski, L. Almadrones, P. E. Saigo, E. Venkatraman, C. Hudis, and W. J. Hoskins
  JCO Oct 20 2000: 3459–3463. [Abstract] [Full Text] [PDF]  
Effects of Adjuvant Tamoxifen on the Endometrium in Postmenopausal Women With Breast Cancer: A Prospective Long-Term Study Using Transvaginal Ultrasound
  Bernd Gerber, Annette Krause, Heiner Müller, Toralf Reimer, Thomas Külz, Josef Makovitzky, Guenter Kundt, and Klaus Friese
  JCO Oct 20 2000: 3464–3470. [Abstract] [Full Text] [PDF]  
HER-2/neu and p53 Expression Versus Tamoxifen Resistance in Estrogen Receptor–Positive, Node-Positive Breast Cancer
  Donald A. Berry, Hyman B. Muss, Ann D. Thor, Lynn Dressler, Edison T. Liu, Gloria Broadwater, Dan R. Budman, I. Craig Henderson, Maurice Barcos, Daniel Hayes, and Larry Norton
  JCO Oct 20 2000: 3471–3479. [Abstract] [Full Text] [PDF]  
Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer
  Tara M. Breslin, Lisa Cohen, Aysegul Sahin, Jason B. Fleming, Henry M. Kuerer, Lisa A. Newman, Ebrahim S. Delpassand, Rosalyn House, Frederick C. Ames, Barry W. Feig, Merrick I. Ross, S. Eva Singletary, Aman U. Buzdar, Gabriel N. Hortobagyi, and Kelly K. Hunt
  JCO Oct 20 2000: 3480–3486. [Abstract] [Full Text] [PDF]  
Safety and Efficacy Results of a Randomized Trial Comparing Adjuvant Toremifene and Tamoxifen in Postmenopausal Patients With Node-Positive Breast Cancer
  Kaija Holli, Ritva Valavaara, Guillermo Blanco, Vesa Kataja, Päivi Hietanen, Martti Flander, Eero Pukkala, and Heikki Joensuu
  JCO Oct 20 2000: 3487–3494. [Abstract] [Full Text] [PDF]  
Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
  N. Avril, C. A. Rosé, M. Schelling, J. Dose, W. Kuhn, S. Bense, W. Weber, S. Ziegler, H. Graeff, and M. Schwaiger
  JCO Oct 20 2000: 3495–3502. [Abstract] [Full Text] [PDF]  
Routine Chest Roentgenography Is Unnecessary in the Work-Up of Stage I and II Breast Cancer
  E. Alexandra Chen, Gregory A. Carlson, Bret F. Coughlin, William P. Reed, Jr, Jane L. Garb, and James L. Frank
  JCO Oct 20 2000: 3503–3506. [Abstract] [Full Text] [PDF]  
Tamoxifen Adjuvant Treatment Duration in Early Breast Cancer: Initial Results of a Randomized Study Comparing Short-Term Treatment With Long-Term Treatment
  Thierry Delozier, Marc Spielmann, Josette Macé-Lesec’h, Maud Janvier, Catherine Hill, Bernard Asselain, Jean-Pierre Julien, Béatrice Weber, Louis Mauriac, Jean-Christophe Petit, Pierre Kerbrat, Jean-Pierre Malhaire, Philippe Vennin, B. Leduc, and Moïse Namer
  JCO Oct 20 2000: 3507–3512. [Abstract] [Full Text] [PDF]  
 
HEMATOLOGIC MALIGNANCIES Back
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
  Hagop M. Kantarjian, Moshe Talpaz, Terry L. Smith, Jorge Cortes, Francis J. Giles, Mary Beth Rios, Susie Mallard, James Gajewski, Anthony Murgo, Bruce Cheson, and Susan O’Brien
  JCO Oct 20 2000: 3513–3521. [Abstract] [Full Text] [PDF]  
 
BRAIN TUMORS Back
Phase I Trial of Carmustine Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma
  Henry S. Friedman, James Pluda, Jennifer A. Quinn, Reginald B. Ewesuedo, Lina Long, Allan H. Friedman, Ilkcan Cokgor, O. Michael Colvin, Michael M. Haglund, David M. Ashley, Jeremy N. Rich, John Sampson, Anthony E. Pegg, Robert C. Moschel, Roger E. McLendon, James M. Provenzale, Elizabeth S. Stewart, Sandra Tourt-Uhlig, Ana M. Garcia-Turner, James E. Herndon, II, Darell D. Bigner, and M. Eileen Dolan
  JCO Oct 20 2000: 3522–3528. [Abstract] [Full Text] [PDF]  
 
GASTROINTESTINAL CANCER Back
Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer
  Paulo M. Hoff, Nora Janjan, Everardo D. Saad, John Skibber, Christopher Crane, Yvonne Lassere, Karen R. Cleary, Steve Benner, Jacqueline Randolph, James L. Abbruzzese, and Richard Pazdur
  JCO Oct 20 2000: 3529–3534. [Abstract] [Full Text] [PDF]  
 
PHASE I AND CLINICAL PHARMACOLOGY Back
Phase I Trial of 6-Hour Infusion of Glufosfamide, a New Alkylating Agent With Potentially Enhanced Selectivity for Tumors That Overexpress Transmembrane Glucose Transporters: A Study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
  Evangelos Briasoulis, Ian Judson, Nicholas Pavlidis, Philip Beale, Jantien Wanders, Yvonne Groot, Gijbert Veerman, Martina Schuessler, Georg Niebch, Konstantinos Siamopoulos, Eleftheria Tzamakou, Dimitra Rammou, Lisa Wolf, Ruth Walker, and Axel Hanauske
  JCO Oct 20 2000: 3535–3544. [Abstract] [Full Text] [PDF]  
Phase I and Pharmacokinetic Study of Docetaxel and Irinotecan in Patients With Advanced Solid Tumors
  Corinne Couteau, Marie-Laure Risse, Michel Ducreux, Florence Lefresne-Soulas, Alessandro Riva, Anne Lebecq, Pierre Ruffié, Philippe Rougier, François Lokiec, René Bruno, and Jean-Pierre Armand
  JCO Oct 20 2000: 3545–3552. [Abstract] [Full Text] [PDF]  
Phase I Chemotherapy Study of Biochemical Modulation of Folinic Acid and Fluorouracil by Gemcitabine in Patients With Solid Tumor Malignancies
  S. Madajewicz, P. Hentschel, P. Burns, R. Caruso, J. Fiore, M. Fried, H. Malhotra, S. Ostrow, S. Sugarman, and M. Viola
  JCO Oct 20 2000: 3553–3557. [Abstract] [Full Text] [PDF]  
 
ASCO SPECIAL ARTICLE Back
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
Howard Ozer, James O. Armitage, Charles L. Bennett, Jeffrey Crawford, George D. Demetri, Philip A. Pizzo, Charles A. Schiffer, Thomas J. Smith, George Somlo, James C. Wade, James L. Wade, III, Rodger J. Winn, Antoinette J. Wozniak, Mark R. Somerfield, and for the American Society of Clinical Oncology Growth Factors Expert Panel
JCO Oct 20 2000: 3558–3585. [Full Text] [PDF]  
 
ASCO SPECIAL ARTICLES Back
2000 Update of American Society of Clinical Oncology Colorectal Cancer Surveillance Guidelines
Al B. Benson, III, Christopher E. Desch, Patrick J. Flynn, Carol Krause, Charles L. Loprinzi, Bruce D. Minsky, Nicholas J. Petrelli, David G. Pfister, Thomas J. Smith, and Mark R. Somerfield
JCO Oct 20 2000: 3586–3588. [Full Text] [PDF]  
 
SPECIAL DEPARTMENTS Back

ERRATA Back

ERRATA
JCO Oct 20 2000: 3589. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online